AI Assistant
Blog
Pricing
Log In
Sign Up
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
